Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

PLEK2 Gene Upregulation Might Independently Predict Shorter Progression-Free Survival in Lung Adenocarcinoma

1 Jan 2020

Abstract excerpt

Objective: This study aimed to explore PLEK2 expression profile, its prognostic value, and the potential genomic alterations associated with its dysregulation in lung adenocarcinoma (LUAD) and lung squamous cell carcinoma (LUSC). Materials and methods: Data from The Cancer Genome Atlas (TCGA), The Genotype-Tissue Expression (GTEx), and Kaplan-Meier plotter were used in combination for bioinformatic analysis....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Genomics and Diagnostics
Share to Ferroptosis and cancer prognosis
Share to Genetic factors in colorectal cancer

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 33084541
DOI: 10.1177/1533033820957030

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

PLEK2 Gene Upregulation Might Independently Predict Shorter Progression-Free Survival in Lung AdenocarcinomaPMID 33084541Read ↗

PLEK2 activates the PI3K/AKT signaling pathway to drive lung adenocarcinoma progression by upregulating SPC25Semantic proximity Read ↗

PLEK2 promotes lung adenocarcinoma progression via activating the PI3K/AKT signaling pathway through SPC25 Running title: PLEK2 promotes LUAD via SPC25/PI3K/AKT axisSemantic proximity Read ↗

FOXA1 Targets NEK2 to Mediate Cisplatin Resistance in Lung Adenocarcinoma Cells by Activating DNA Damage RepairSemantic proximity Read ↗

TGF-β-induced PLEK2 promotes metastasis and chemoresistance in oesophageal squamous cell carcinoma by regulating LCN2.Semantic proximity Read ↗

Comprehensive transcriptome, miRNA and kinome profiling and its clinical translation for personalized lung cancer therapySemantic proximity Read ↗

Analyses of expressions and prognostic values of Polo-like kinases in non-small cell lung cancer.Semantic proximity Read ↗

Genome-scale analysis identifies NEK2, DLGAP5 and ECT2 as promising diagnostic and prognostic biomarkers in human lung cancerSemantic proximity Read ↗

Prognostic significance and molecular mechanisms of LPCAT1 in lung squamous cell carcinomaSemantic proximity Read ↗

Identification of Key Genes Related to Lung Squamous Cell Carcinoma Using Bioinformatics AnalysisSemantic proximity Read ↗

Comprehensive genomic characterization of squamous cell lung cancers.Semantic proximity Read ↗

Prognosis and Immunological Characteristics of PGK1 in Lung Adenocarcinoma: A Systematic AnalysisSemantic proximity Read ↗

Akt kinase LANCL2 functions as a key driver in EGFR-mutant lung adenocarcinoma tumorigenesis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.